Abstract:Purpose: Breast cancer treatments are based on prognostic clinicopathologic features that form the basis for therapeutic guidelines. Although the utilization of these guidelines has decreased breast cancer-associated mortality rates over the past three decades, they are not adequate for individualized therapy. Radiation therapy (RT) is the backbone of breast cancer treatment. Although a highly successful therapeutic modality clinically, from a biological perspective, preclinical studies have shown RT to have the potential to alter tumor cell phenotype, immunogenicity, and the surrounding microenvironment, potentially changing the behavior of cancer cells and resulting in a significant variation in RT response. This review presents the recent advances in revealing the complex molecular changes induced by RT in the treatment of breast cancer and highlights the complexities of translating this information into clinically relevant tools for improved prognostic insights and the revelation of novel approaches for optimizing RT. Methods and materials: Current literature was reviewed with a focus on recent advances made in the elucidation of tumor-associated radiation-induced molecular changes across molecular, genetic, and proteomic bases. This review was structured with the aim of providing an up-to-date overview over the very broad and complex subject matter of radiation-induced molecular changes and radioresistance, familiarizing the reader with the broader issue at hand. Results: The subject of radiation-induced molecular changes in breast cancer has been broached from various physiological focal points including that of the immune system, immunogenicity and the abscopal effect, tumor hypoxia, breast cancer classification and subtyping, molecular heterogeneity, and molecular plasticity. It is becoming increasingly apparent that breast cancer clinical subtyping alone does not adequately account for variation in RT response or radioresistance. Multiple components of the tumor microenvironment and immune system, delivered RT dose and fractionation schedules, radiation-induced bystander effects, and intrinsic tumor physiology and heterogeneity all contribute to the resultant RT outcome. Conclusions: Despite recent advances and improvements in anticancer therapies, tumor resistance remains a significant challenge. As new analytical techniques and technologies continue to provide crucial insight into the complex molecular mechanisms of breast cancer and its treatment responses, it is becoming more evident that personalized anticancer treatment regimens may be vital in overcoming radioresistance.

Radiation-induced Adaptive Response: New Potential for Cancer Treatment

Making Radiation Therapy More Effective in the Era of Precision Medicine

Molecular landscape of FaDu xenograft tumors in mice after a combinatorial treatment with radiation and an HSP90 inhibitor identifies adaptation-induced targets

A survivin-associated adaptive response in radiation therapy

Radiation-induced Tumor Immune Microenvironments and Potential Targets for Combination Therapy

Molecular Changes in Breast Cancer Induced by Radiation Therapy

Emerging strategies to target cancer metabolism and improve radiation therapy outcomes

Radiation therapy and the innate immune response: Clinical implications for immunotherapy approaches

Emerging evidence for adapting radiotherapy to immunotherapy

Molecular mechanisms of sensitivity and resistance to radiotherapy

The Molecular and Cellular Basis of Radiosensitivity: Implications for Understanding How Normal Tissues and Tumors Respond to Therapeutic Radiation

Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer

Targeting Innate Immunity to Enhance the Efficacy of Radiation Therapy

Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization

Understanding the molecular mechanism responsible for developing therapeutic radiation-induced radioresistance of rectal cancer and improving the clinical outcomes of radiotherapy - A review

Mechanisms for Tuning Engineered Nanomaterials to Enhance Radiation Therapy of Cancer

The immunological consequences of radiation-induced DNA damage

Synergistic effects of radiotherapy and targeted immunotherapy in improving tumor treatment efficacy: a review

The immunogenic radiation and new players in immunotherapy and targeted therapy for head and neck cancer

Immune targets in the tumor microenvironment treated by radiotherapy

Receptor tyrosine kinase signaling in cancer radiotherapy and its targeting for tumor radiosensitization